Marco Tognetti

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Lacey Padrón, Deena M. Maurer, Mark H. O’Hara et al. · Nature Medicine · 2022 · 316 citations · Full text

Randomized Phase 2, Pancreatic Cancer, Gastrointestinal Oncology +13

Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN

Nausica Arnoult, Adriana Correia, Jiao Ma et al. · Nature · 2017 · 279 citations · Full text

Nhej Inhibitor Cyren, Chromatin, Genome Instability +9

A sentinel protein assay for simultaneously quantifying cellular processes

Martin Soste, Rita Hrabáková, Stefanie Wanka et al. · Nature Methods · 2014 · 75 citations

Sentinel Protein, Immunocytochemical Technique, Reporter Gene Assay +6

Biomarker Candidates for Tumors Identified from Deep-Profiled Plasma Stem Predominantly from the Low Abundant Area

Marco Tognetti, Kamil Skłodowski, Sebastian Müller et al. · Journal of Proteome Research · 2022 · 69 citations · Full text

Engineering, Pathology, Deep Plasma Profiling +23

Influence of node abundance on signaling network state and dynamics analyzed by mass cytometry

Xiao‐Kang Lun, Vito Riccardo Tomaso Zanotelli, James D. Wade et al. · Nature Biotechnology · 2017 · 51 citations

Biology, Signal Transduction, Node Abundance +15